Switching risk and protective alleles improves Alzheimer's-disease-like signatures and disruptions in mice

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive degradation of brain cells, as well ...

Dementia Comes in Many Forms. Alzheimer’s Is Just One.

Alzheimer’s disease is the most commonly diagnosed form of dementia, but it’s far from the only one. In fact, most people who ...

Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer's Disease

Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and ...

Popular fat jab could slow Alzheimer’s by slashing brain shrinkage and boosting memory

A FAT jab could help slow down Alzheimer’s by slashing brain shrinkage, according to a small British study. Liraglutide, the ...
University at Buffalo

FDA-approved screen for Alzheimer’s boost for nursing wet lab

The test confirms the scientific validity of the biomarkers used in the lab, led by researcher Carleara Weiss, and increases ...

Neurologist explains early symptoms of Alzheimer’s and 7 ways to reduce your risk

Alzheimer’s disease does not happen overnight. It comes on slowly, with early warning signs that are often easy to miss. And ...

What the air you breathe may be doing to your brain

Evidence increasingly shows that chronic exposure to PM2.5, a neurotoxin, not only damages lungs and hearts but is also ...
ScienceAlert on MSN

Switch Turns Brain's Defenses Into Protectors Against Alzheimer's

Specific immune cells in the brain may play a crucial role in preventing the onset of Alzheimer's disease, according to a new ...
Study Finds

Weight-Loss Drug Doesn’t Reduce Risk Of Alzheimer’s – New Studies

Semaglutide, the drug behind weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline among people with ...
Becker's Hospital Review

Merck Alzheimer’s drug granted FDA fast-track designation

Merck’s investigational antibody MK-2214 has received fast-track designation from the FDA for the treatment of Alzheimer’s disease. MK-2214 targets phosphorylated serine 413 tau (pS413), a marker of ...
Mathrubhumi English

Sitting all day? Weak legs could be hurting your brain, experts warn

Did you know weak leg muscles accelerate cognitive decline & dementia risk after 40? Learn how to strengthen legs for better ...

Huge Alzheimer's breakthrough as weight loss jab already prescribed to thousands on the NHS is found to slow progression of memory robbing illness

Liraglutide - sold under the brand name Saxenda - is often offered to people with with a BMI of over 30 as it improves blood sugar control and aids weight loss.